{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T23:43:24Z","timestamp":1747784604128},"reference-count":41,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,10,1]]},"abstract":"<jats:p>Twenty consecutive patients with adrenal Cushing\u2019s syndrome were studied with an in vivo protocol to determine the prevalence and diversity of the presence of ectopic or abnormal hormone receptors in their adrenal tissues. All six patients with bilateral ACTH-independent macronodular adrenal hyperplasia were found to have one or two abnormal adrenal receptors, including those for gastric inhibitory polypeptide, vasopressin (V1-vasopressin),\u03b2 -adrenergic agonists, LH\/human CG, or serotonin 5-HT4. The presence of abnormal hormone receptors was found to be less frequently present in unilateral adenomas or carcinomas (3 of 14). The identification of abnormal adrenal hormone receptors can allow new pharmacological therapies of hypercortisolism. We suggest that the clinical screening for the presence of abnormal hormone receptors should be conducted in patients with adrenal Cushing\u2019s syndrome and, more particularly, in those with ACTH-independent macronodular adrenal hyperplasia, in the hope of offering medical therapy as an alternative to bilateral adrenalectomy.<\/jats:p>","DOI":"10.1210\/jcem.85.10.6865","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:05:10Z","timestamp":1389200710000},"page":"3531-3536","source":"Crossref","is-referenced-by-count":7,"title":["Are Ectopic or Abnormal Membrane Hormone Receptors Frequently Present in Adrenal Cushing\u2019s Syndrome?1"],"prefix":"10.1210","volume":"85","author":[{"given":"Hortensia","family":"Mircescu","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Research Center, Ho\u0302tel-Dieu du Centre Hospitalier de l\u2019Universite\u0301 de Montre\u0301al, Montre\u0301al, Canada H2W 1T8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Jilwan","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Research Center, Ho\u0302tel-Dieu du Centre Hospitalier de l\u2019Universite\u0301 de Montre\u0301al, Montre\u0301al, Canada H2W 1T8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"N\u2032Diaye","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Research Center, Ho\u0302tel-Dieu du Centre Hospitalier de l\u2019Universite\u0301 de Montre\u0301al, Montre\u0301al, Canada H2W 1T8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Bourdeau","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Research Center, Ho\u0302tel-Dieu du Centre Hospitalier de l\u2019Universite\u0301 de Montre\u0301al, Montre\u0301al, Canada H2W 1T8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanne","family":"Tremblay","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Research Center, Ho\u0302tel-Dieu du Centre Hospitalier de l\u2019Universite\u0301 de Montre\u0301al, Montre\u0301al, Canada H2W 1T8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Hamet","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Research Center, Ho\u0302tel-Dieu du Centre Hospitalier de l\u2019Universite\u0301 de Montre\u0301al, Montre\u0301al, Canada H2W 1T8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre\u0301","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Research Center, Ho\u0302tel-Dieu du Centre Hospitalier de l\u2019Universite\u0301 de Montre\u0301al, Montre\u0301al, Canada H2W 1T8"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071617384365800_R1","article-title":"Cushing\u2019s syndrome. In: De Groot LJ, Besser M, Burger HG, et al., eds","author":"Nieman","year":"1995"},{"key":"2020071617384365800_R2","first-page":"1317","article-title":"Extensive personal experience: adrenocortical tumors.","volume":"82","author":"Latronico","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-130-9-199905040-00017","article-title":"Adrenocortical tumors: recent advances in basic concepts and clinical management.","volume":"130","author":"Bornstein","year":"1999","journal-title":"Ann Intern Med"},{"key":"2020071617384365800_R4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-\u03b1 regulatory subunit in patients with the Carney complex.","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"key":"2020071617384365800_R5","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"Weinstein","journal-title":"N Engl J Med"},{"key":"2020071617384365800_R6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI106608","article-title":"Abnormal hormone responses of an adrenocortical cancer adenylyl cyclase.","volume":"50","author":"Schorr","year":"1971","journal-title":"J Clin Invest"},{"key":"2020071617384365800_R7","article-title":"Abnormal control in the neoplastic adrenal cortex. In: McKerns KW, ed","author":"Hingshaw","year":"1974"},{"key":"2020071617384365800_R8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1172\/JCI108643","volume":"59","author":"Williams","journal-title":"J Clin Invest"},{"key":"2020071617384365800_R9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/acta.0.0820561","article-title":"In vitro synthesis of steroids by a feminising adrenocortical carcinoma: effect of prolactin and other protein hormones.","volume":"82","author":"Millington","year":"1976","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071617384365800_R10","first-page":"3768","article-title":"Multiple hormone receptors in the adenylate cyclase of human adrenocortical tumors.","volume":"40","author":"Matsukura","year":"1980","journal-title":"Cancer Res"},{"key":"2020071617384365800_R11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jcem-53-5-953","article-title":"Presence of ectopic \u03b2-adrenergic receptors on human adrenocortical cortisol producing adenomas.","volume":"53","author":"Hirata","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1210\/jcem-60-5-900","article-title":"Ectopic \u03b2-adrenergic receptors coupled to adenylate cyclase in human adrenocortical carcinomas.","volume":"60","author":"Katz","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2265.1991.tb01732.x","article-title":"Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors, and 21-hydroxylase deficiency.","volume":"34","author":"Leinonen","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617384365800_R14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJM199807023390105","article-title":"Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing\u2019s syndrome.","volume":"339","author":"Willenberg","year":"1998","journal-title":"N Engl J Med"},{"key":"2020071617384365800_R15","first-page":"530","article-title":"Cushing\u2019s syndrome with food-dependent periodic hormonogenesis.","volume":"10","author":"Hamet","year":"1987","journal-title":"Clin Invest Med"},{"key":"2020071617384365800_R16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199210013271402","article-title":"Gastric inhibitory polypeptide-dependent cortisol hypersecretion: a new cause of Cushing\u2019s syndrome.","volume":"327","author":"Lacroix","year":"1992","journal-title":"N Engl J Med"},{"key":"2020071617384365800_R17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM199210013271403","article-title":"Food-dependent Cushing\u2019s syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.","volume":"327","author":"Reznik","year":"1992","journal-title":"N Engl J Med"},{"key":"2020071617384365800_R18","first-page":"3168","article-title":"Food-dependent Cushing\u2019s syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells.","volume":"81","author":"De Herder","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R19","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/jcem.83.8.5038","article-title":"Adrenal overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing\u2019s syndrome.","volume":"83","author":"N\u2032Diaye","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R20","first-page":"3134","article-title":"Cushing\u2019s syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis.","volume":"83","author":"Chabre","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R21","first-page":"4514","article-title":"Food-dependent Cushing\u2019s syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients.","volume":"83","author":"Lebrethon","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R22","first-page":"1839","article-title":"Aberrant expression of GIP (gastric inhibitory polypeptide) receptor in an adrenal cortical adenoma responsible for a case of food-dependent Cushing\u2019s syndrome.","volume":"182","author":"Luton","year":"1998","journal-title":"Bull Acad Natl Med"},{"key":"2020071617384365800_R23","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1210\/jcem.84.8.5930","article-title":"Asynchronous development of bilateral nodular adrenal hyperplasia in GIP-dependent Cushing\u2019s syndrome.","volume":"84","author":"N\u2032Diaye","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R24","first-page":"2661","article-title":"Vasopressin-responsive adrenocortical tumor in a mild Cushing\u2019s syndrome: in vivo and in vitro studies.","volume":"80","author":"Perraudin","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R25","first-page":"2336","article-title":"Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.","volume":"80","author":"Horiba","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R26","first-page":"2414","article-title":"Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing\u2019s syndrome and orthostatic hypotension.","volume":"82","author":"Lacroix","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2265.1997.3011151.x","article-title":"Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide.","volume":"47","author":"Iida","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617384365800_R28","first-page":"2029","article-title":"Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors.","volume":"83","author":"Arnaldi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R29","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM199711133372004","article-title":"Propranolol therapy for ectopic \u03b2-adrenergic receptors in adrenal Cushing\u2019s syndrome.","volume":"337","author":"Lacroix","year":"1997","journal-title":"N Engl J Med"},{"key":"2020071617384365800_R30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","article-title":"Control of hypercortisolism with leuprolide acetate therapy in LH-dependent adrenal Cushing\u2019s syndrome.","volume":"341","author":"Lacroix","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071617384365800_R31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00019616-199901000-00004","article-title":"Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing\u2019s syndrome.","volume":"9","author":"Lacroix","year":"1999","journal-title":"Endocrinologist"},{"key":"2020071617384365800_R32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1310067","article-title":"ACTH-independent massive bilateral adrenal disease (AIMBAD): a subtype of Cushing\u2019s syndrome with major diagnostic, and therapeutic implications.","volume":"131","author":"Lieberman","year":"1994","journal-title":"Eur J Clin Endocrinol"},{"key":"2020071617384365800_R33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-2007-978914","article-title":"Clinical, and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing\u2019s syndrome.","volume":"30","author":"Stratakis","year":"1998","journal-title":"Horm Metab Res"},{"key":"2020071617384365800_R34","first-page":"3817","article-title":"Food-dependent Cushing\u2019s syndrome: possible involvement of leptin in cortisol hypersecretion.","volume":"84","author":"Pralong","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R35","first-page":"875","article-title":"No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms.","volume":"80","author":"Latronico","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R36","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/0024-3205(95)00114-L","article-title":"Are activating mutations of the ACTH receptor involved in adrenal cortical neoplasia?","volume":"56","author":"Light","year":"1995","journal-title":"Life Sci"},{"key":"2020071617384365800_R37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1172\/JCI7716","article-title":"Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex.","volume":"105","author":"Kero","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071617384365800_R38","first-page":"1522","article-title":"Vasopressin stimulates cortisol secretion from human adrenocortical tissues through activation of V1 receptors.","volume":"76","author":"Perraudin","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617384365800_R39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-2007-978904","article-title":"Serotonergic regulation of adrenocortical function.","volume":"30","author":"Lefebvre","year":"1998","journal-title":"Horm Metab Res"},{"key":"2020071617384365800_R40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/07435809809032672","article-title":"Vasopressin: a potent autocrine\/paracrine regulator of mammal adrenal functions.","volume":"24","author":"Guillon","year":"1998","journal-title":"Endocr Res"},{"key":"2020071617384365800_R41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1677\/joe.0.1170027","article-title":"Immunoreactive vasopressin, and oxytocin in hypothalamo-hypophysial portal blood of the Brattleboro and Long Evans rat: effect of adrenalectomy and dexamethasone.","volume":"117","author":"Eckland","year":"1988","journal-title":"J Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/10\/3531\/10401586\/jcem3531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/10\/3531\/10401586\/jcem3531.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:34:42Z","timestamp":1594956882000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/10\/3531\/2851574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,1]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2000,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.10.6865","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10,1]]}}}